$10.86
Today
as of Sep 4, 16:48 ET
Last 30 days
Recent Press Releases & News
Eikon Therapeutics Appoints Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer
Eikon Therapeutics to Participate in Investor Conferences in September 2026
Eikon Therapeutics Eyes Safer PARP1 Cancer Treatments With EIK1003, EIK1004
Overview
52-week range
$7.90
$17
31% of range
Avg surprise (last 1)
-67.3%
Avg reaction (last 1)
-0.1%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-1.63 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-2.46 | $-1.47 | -67.3% | — | -0.1% | earnings |
| Mon Jun 30, 2025 | Jun 2025 | $-36.94 | — | — | — | — | financials |
| Mon Mar 31, 2025 | Mar 2025 | $-26.91 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | $-93M | $-87M | — | $-110M | $-71M |
| Net income | $-88M | $-83M | — | $-105M | $-68M |
| EPS (diluted) | $-1.63 | $-2.46 | — | $-36.94 | $-26.91 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $143M | $161M | $105M | $137M | $205M |
| Inventory | — | — | — | — | — |
| Total current assets | $547M | $530M | $349M | — | — |
| Total assets | $780M | $851M | $595M | — | — |
| Long-term debt | — | — | — | — | — |
| Total liabilities | $313M | $300M | $312M | — | — |
| Total equity | $466M | $551M | $-879M | $-738M | $-640M |
Implied volatility — last 90 days
No IV snapshots yet for EIKN.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.